Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis

• Benjamin Maasoumy ,

  Contributed equally to this work with: Benjamin Maasoumy, Bela Hunyady

  Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hanover, Germany

  ⨯
• Bela Hunyady ,

  Contributed equally to this work with: Benjamin Maasoumy, Bela Hunyady

  Affiliations Somogy County Kaposi Mor Teaching Hospital, Kaposvar, Hungary, University of Pecs, Pecs, Hungary

  ⨯
• Vincenza Calvaruso,

  Affiliation Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy

  ⨯
• Mihály Makara,

  Affiliation Outpatient Clinic, Saint Laszlo Hospital, Budapest, Hungary

  ⨯
• Johannes Vermehren,

  Affiliation Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany

  ⨯
• Attila Haragh,

  Affiliation Somogy County Kaposi Mor Teaching Hospital, Kaposvar, Hungary

  ⨯
• Simone Susser,

  Affiliation Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany

  ⨯
• Birgit Bremer,

  Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hanover, Germany

  ⨯
• Gavin Cloherty,

  Affiliation Abbott Molecular, Des Plaines, Illinois, United States of America

  ⨯
• Michael P. Manns,

  Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hanover, Germany

  ⨯
• Antonio Craxì,

  Affiliation Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy

  ⨯
• Heiner Wedemeyer,

  Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hanover, Germany

  ⨯
• Christoph Sarrazin

  * E-mail: sarrazin@em.uni-frankfurt.de

  Affiliation Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany

  ⨯